Retinal ganglion cell loss induced by acute optic neuritis in a relapsing model of multiple sclerosis

被引:71
作者
Shindler, Kenneth S.
Guan, Yangtai
Ventura, Elviro
Bennett, Jean
Rostami, Abdolmohamad
机构
[1] Univ Penn, Scheie Eye Inst, Dept Ophthalmol, Philadelphia, PA 19104 USA
[2] Thomas Jefferson Univ, Dept Neurol, Philadelphia, PA 19107 USA
关键词
experimental autoimmune encephalomyelitis; multiple sclerosis; myelin proteolipid protein; optic nerve; optic neuritis; retinal ganglion cell;
D O I
10.1177/1352458506070629
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Multiple sclerosis(MS)and its animal model experimental autoimmune encephalomyelitis (EAE) are marked by inflammatory demyelinating lesions throughout the central nervous system, including;optic nerve. Neuronal loss also occurs in MS and EAE lesions, but it is not known whether neuronal to loss occurs. secondary inflammation, or as a primary process. In the current study, the relationship of inflammation to retinal ganglion cell (RGC) loss during acute optic neuritis is examined. RGCs were labelled with Flourogold, and EAE was induced in SJL/J mice by immunization with proteolipid protein peptide 139-151 (PLP). At various time points, RGCs were counted and optic nerves were examined for inflammatory cell infiltrates. No optic neuritis was detected prior to day 9 following immunization. Incidence of optic neuritis was 30% at day 9 and increased to over 70% by day 11, remaining high through day 18. In contrast, no RGC loss was detected in eyes with optic neuritis until day 14. A 43.1% reduction in RGC numbers at day 14 increased to 50.8% by day 18. No RGC loss occurred in eyes without optic neuritis. The fact that inflammation precedes RGC loss suggests that neuronal loss during optic neuritis occurs secondary to the inflammatory process.
引用
收藏
页码:526 / 532
页数:7
相关论文
共 35 条
[1]  
Anderson A, 2004, ARCH IMMUNOL THER EX, V52, P316
[2]   Evolving management of optic neuritis and multiple sclerosis [J].
Arnold, AC .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2005, 139 (06) :1101-1108
[3]  
Baranzini SE, 2002, GENOME BIOL, V3
[4]   THE CLINICAL PROFILE OF OPTIC NEURITIS - EXPERIENCE OF THE OPTIC NEURITIS TREATMENT TRIAL [J].
BECH, RW .
ARCHIVES OF OPHTHALMOLOGY, 1991, 109 (12) :1673-1678
[5]   A RANDOMIZED, CONTROLLED TRIAL OF CORTICOSTEROIDS IN THE TREATMENT OF ACUTE OPTIC NEURITIS [J].
BECK, RW ;
CLEARY, PA ;
ANDERSON, MM ;
KELTNER, JL ;
SHULTS, WT ;
KAUFMAN, DI ;
BUCKLEY, EG ;
CORBETT, JJ ;
KUPERSMITH, MJ ;
MILLER, NR ;
SAVINO, PJ ;
GUY, JR ;
TROBE, JD ;
MCCRARY, JA ;
SMITH, CH ;
CHROUSOS, GA ;
THOMPSON, HS ;
KATZ, BJ ;
BRODSKY, MC ;
GOODWIN, JA ;
ATWELL, CW .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (09) :581-588
[6]   Visual function more than 10 years after optic neuritis: Experience of the optic neuritis treatment trial [J].
Beck, RW ;
Gal, RL ;
Bhatti, MT ;
Brodsky, MC ;
Buckley, EG ;
Chrousos, GA ;
Corbett, J ;
Eggenberger, E ;
Goodwin, JA ;
Katz, B ;
Kaufman, DI ;
Keltner, JL ;
Kupersmith, MJ ;
Miller, NR ;
Moke, PS ;
Nazarian, S ;
Orengo-Nania, S ;
Savino, PJ ;
Shults, WT ;
Smith, CH ;
Trobe, JD ;
Wall, M ;
Xing, DY .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2004, 137 (01) :77-83
[7]   Myelin oligodendrocyte glycoprotein-specific T cell receptor transgenic mice develop spontaneous autoimmune optic neuritis [J].
Bettelli, E ;
Pagany, M ;
Weiner, HL ;
Linington, C ;
Sobel, RA ;
Kuchroo, AK .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 197 (09) :1073-1081
[8]  
Bjartmar C, 2000, ANN NEUROL, V48, P893, DOI 10.1002/1531-8249(200012)48:6<893::AID-ANA10>3.3.CO
[9]  
2-2
[10]   CHRONIC EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS PRODUCED BY BOVINE PROTEOLIPID APOPROTEIN - IMMUNOLOGICAL STUDIES IN RABBITS [J].
CAMBI, F ;
LEES, MB ;
WILLIAMS, RM ;
MACKLIN, WB .
ANNALS OF NEUROLOGY, 1983, 13 (03) :303-308